The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of circulating tumor DNA to predict survival in patients with resected high-risk stage II/III melanoma.
 
Rebecca Lee
No Relationships to Disclose
 
Gabriela Gremel
No Relationships to Disclose
 
Andrea Marshall
No Relationships to Disclose
 
Kevin A Myers
Patents, Royalties, Other Intellectual Property - Oxford Biomedica
 
Nita Fisher
No Relationships to Disclose
 
Philippa Corrie
Consulting or Advisory Role - Baxalta; Bristol-Myers Squibb; Celgene; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Janet Dunn
No Relationships to Disclose
 
Nathalie Dhomen
No Relationships to Disclose
 
Mark R. Middleton
Honoraria - Bristol-Myers Squibb; Merck; Roche; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis
Research Funding - AstraZeneca; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Immunocore; Merck; Novartis; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Merck
 
Richard Marais
Research Funding - Basilea
Patents, Royalties, Other Intellectual Property - Institute of Cancer Research, rewards
 
Paul Lorigan
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme